Intuitive Surgical Inc

Find Ratings Reports
ISRG : NASDAQ : Health Care
$758.0 | %
Today's Range: 747.67 - 761.51
Avg. Daily Volume: 345200.0
03/24/17 - 4:00 PM ET

Financial Analysis


INTUITIVE SURGICAL INC's gross profit margin for the fourth quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. INTUITIVE SURGICAL INC is extremely liquid. Currently, the Quick Ratio is 5.05 which clearly shows the ability to cover any short-term cash needs. ISRG managed to increase the liquidity from the same period a year ago, despite already having very strong liquidity to begin with. This would indicate improved cash flow.

At the same time, stockholders' equity ("net worth") has greatly increased by 33.76% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q4 FY16 Q4 FY15
Net Sales ($mil)756.9676.5
EBITDA ($mil)0.0266.5
EBIT ($mil)266.4245.9
Net Income ($mil)204.0190.0


Balance Sheet Q4 FY16 Q4 FY15
Cash & Equiv. ($mil)2554.61559.8
Total Assets ($mil)6486.94907.3
Total Debt ($mil)0.00.0
Equity ($mil)5777.84319.5


Profitability Q4 FY16 Q4 FY15
Gross Profit Margin69.6570.86
EBITDA Margin0.039.39
Operating Margin35.236.35
Sales Turnover0.420.49
Return on Assets11.3411.99
Return on Equity12.7313.63
Debt Q4 FY16 Q4 FY15
Current Ratio5.454.46
Debt/Capital0.00.0
Interest Expense0.00.0
Interest Coverage0.00.0


Share Data Q4 FY16 Q4 FY15
Shares outstanding (mil)38.837.4
Div / share0.00.0
EPS5.134.99
Book value / share148.91115.49
Institutional Own % n/a n/a
Avg Daily Volume339124.0368856.0

Valuation


BUY. The current P/E ratio indicates a significant discount compared to an average of 51.83 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 26.73. Conducting a second comparison, its price-to-book ratio of 4.99 indicates a significant premium versus the S&P 500 average of 2.98 and a premium versus the industry average of 4.66. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ISRG 39.78 Peers 51.83   ISRG 27.66 Peers 25.63

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

ISRG is trading at a discount to its peers.

 

Average. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

ISRG is trading at a valuation on par to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
ISRG 28.06 Peers 41.13   ISRG 1.58 Peers 1.13

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

ISRG is trading at a discount to its peers.

 

Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

ISRG trades at a significant premium to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ISRG 4.99 Peers 4.66   ISRG 20.42 Peers 96.34

Average. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

ISRG is trading at a valuation on par with its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, ISRG is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ISRG 10.67 Peers 5.36   ISRG 13.42 Peers 14.70

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ISRG is trading at a significant premium to its industry.

 

Average. Comparing a company's sales growth to its industry helps to determine if the company is adding or losing market share.

ISRG is keeping pace with its peers on the basis of sales growth.

 

 

Latest Stock Upgrades/Downgrades